CAPLIN POINT LABORATORIES
Live / Applied — Statement of use — non-final action mailed (as of 19 Feb 2026)
What this means for you
Not registered yet, but its 24 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98148403
- Mark type
- Design + words
- Filed
- 24 Aug 2023
- Published for opposition
- 25 Mar 2025
- Attorney of record
- Touhey Myer
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic preparations
- Class 035 — Advertising and business services: Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
Owner
- Caplin Point Laboratories Limited, Chennai, IN
- Caplin Point Laboratories Limited, Chennai, IN
Prosecution history
- 19 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Feb 2026 — NON-FINAL ACTION E-MAILED
- 19 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 24 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jul 2025 — USE AMENDMENT FILED
- 24 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED